Novozymes Reports Q2 Revenue Growth of 9.8% Year-over-Year and Raises FY26 Organic Sales Outlook
Novozymes A/S reported a strong second-quarter performance, with revenue rising to €1.12 billion—a year-over-year increase of 9.8%. The company attributed the growth to broad-based organic sales expansion of 8%, despite challenges from exiting certain countries that negatively impacted results by approximately 1.5 percentage points. The firm also raised its full-year outlook for organic sales growth and maintained a robust Adjusted EBITDA margin at 37.7%. This performance reflects improved operational efficiency, with the company reporting an increase in adjusted EBITDA margins compared to previous periods.
Topics: Adjusted EBITDA Earnings Non-GAAP EPS Revenue Growth